Introduction -- Test Data Exclusivity: Raison d'être -- Test Data Exclusivity and Art 39(3) TRIPS -- Test Data Exclusivity in the US and the EU -- Index of Data Exclusivity and Access (IDEAS) -- Free Trade Agreements -- Index of Data Exclusivity and Access (IDEAS) -- National Laws -- Test Data...

Until recently, the link between the examination of patents carried out by national patent offices and the right of citizens to access to medicines was not at all clear. They were two functions or responsibilities of the State that apparently had nothing to do with each other. Examining the...

This document discusses criteria for implementing the patentability requirements in relation to patent applications covering products and processes, as well as the use of pharmaceutical products. The adoption of rigorous criteria with this purpose is important for four main reasons.

This paper attempts to give an overview of the debate surrounding the patentability of new therapeutic uses for known active ingredients, both in developed and developing countries. After close scrutiny of international patentability standards, this paper concludes that second medical uses do...

Until recently, the link between the examination of patents carried out by national patent offices and the right of citizens to access to medicines was not at all clear. They were two functions or responsibilities of the State that apparently had nothing to do with each other. Examining the...